Options for managing cancer risk among patients with a BRCA1 or BRCA2 mutation
If you're a healthcare provider who is involved in the care of women at high risk for breast or ovarian cancer, we’d like to invite you to participate in this study.
Women with a BRCA1 or BRCA2 mutation are at higher risk of developing breast and/or ovarian cancer compared to women in the general population. There are options available to women to help reduce or manage these risks, including preventive surgery and screening.
To understand the cancer prevention decisions that women make, Dr. Joanne Kotsopoulos, PhD and Dr. Steven Narod, MD are conducting an important new study to investigate why women have chosen the cancer management options that they have, and if healthcare provider recommendations influence the uptake of certain preventive options.
This information will help in understanding why there are differences in uptake of cancer preventive and/or screening options and help improve the clinical care of this high-risk group.
Who can participate?
If you are interested in participating, you must meet the following eligibility criteria:
- A healthcare provider
- Is currently involved in the care of women at high risk for breast or ovarian cancer
This study is voluntary and you can withdraw at any time.
What does participation entail?
Participation requires the completion of one short, online, easy-to-use survey. The survey collects information related to healthcare provider perspective on cancer management options, including preventive surgery. This survey will require 15-20 minutes of your time. Upon completion of the survey, you will receive a gift card to thank you for your participation.
If you are interested in participating or learning more about this study, please contact the study coordinator:
416-323-6400 Ext. 2761
This research is funded by: Canadian Institutes of Health Research (CIHR)